Skip to content

A Study to Assess the Effectiveness of Homoeopathic Medicine Aranea diadema in People with Heel Pain.

An Observational Study To Assess The Therapeutic Effectiveness Of Aranea Diadema In Plantar Fasciitis. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/07/113640
Enrollment
53
Registered
2026-07-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M722- Plantar fascial fibromatosis

Interventions

Intervention1: Aranea Diadema 30C: Aranea Diadema 30C will be administered orally as medicated globules in a dose of 3 pills three times daily (3-0-3) for 4 weeks Participants will be reviewed once we

Sponsors

Father Muller Research Committee
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The patients of both male and females with age group 40-60 years Clinically diagnosed case of Plantar Fasciitis based on diagnostic criteria ICD 10 CM code M72.2 by positive windlass test Patients for whom Aranea Diadema is indicated

Exclusion criteria

Exclusion criteria: Ruptured plantar fascia Tarsal tunnel syndrome Systemic inflammatory disease like Rheumatoid arthritis, seronegative spondyloarthropathies, lupus Pregnancy or breastfeeding

Design outcomes

Primary

MeasureTime frame
Change in Plantar Fasciitis Disability Pain Scale Score From Baseline to 4weeks following treatment with Aranea Diadema 30CTimepoint: Baseline, Week 1, Week 2, Week 3, Week 4

Secondary

MeasureTime frame
Change in visual analogue scale score for heel painTimepoint: Baseline, week 1, week 2, week 3 and week 4

Countries

India

Contacts

Public ContactDr Monica Sequeira

Father Muller Homoeopathic Medical College And Hospital

drminiiv73@gmail.com9945929772

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026